Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Unlike older GLP-1 medications that target only one hormone, tirzepatide is the first dual GLP-1 (glucagon-like peptide 1) and GIP receptor agonist that offers greater benefits, including stronger appetite suppression, deeper metabolic changes, and more significant weight loss
The risk of multiple myeloma was 41% lower in those taking GLP-1 drugs compared to insulin
[14] For patients with type 2 diabetes, where glucose variability is already a concern, staying at or below 200 to 300 mg/day (roughly 2 to 3 cups of standard drip coffee) reduces pharmacodynamic glucose interference
PlexusDx offers tirzepatide injection and GLP-Squared combinations that activate additional appetite pathways, often producing better results for non-responders
doi: 10.1016/j.immuni.2023.06.021
As currently there is not enough information about the safety of GLP1-RAs during pregnancy, it is recommended to stop GLP1-RAs when planning pregnancy
US$ 26.11
US$ 27.56
US$ 27.41
US$ 28.24
